Acromegaly is a hormonal disorder that results from the availability of excessive growth hormone (GH) in the body, which is produced by the pituitary gland (a small gland in the brain). In acromegaly, the pituitary produces an immoderate amount of GH, which is resulted from benign or noncancerous tumors on the pituitary. These benign tumors are called Adenomas.
The symptoms in acromegaly vary from patient to patient. It can lead to unusual physical features, such as swollen hands and feet, deformities, and complications, with an impact also on muscle strength and bone health.
The Acromegaly market report provides current treatment practices, emerging drugs, Acromegaly market share of the individual therapies, current and forecasted Acromegaly market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Acromegaly treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Key facts of Acromegaly Market report
1. The total number of Acromegaly prevalent cases in 2017 were found to be 61,022 in the 7MM.
2. In the case of the United States, Acromegaly prevalent population was estimated to be 25,451 cases in 2017. Japan was assessed to have 10,755 prevalent cases. In the EU5, the highest prevalent cases were observed in Germany, followed by France and the United Kingdom whereas the lowest prevalent cases were witnessed in Spain, during the period of 2017-2028.
3. The diagnosed patient pool in the 7MM comprised of 30,511 patients in 2017.
Request for Sample Pages: https://www.delveinsight.com/sample-request/acromegaly-market
Key benefits of Acromegaly Market report
Acromegaly market report covers a descriptive overview and comprehensive insight of the Acromegaly epidemiology and Acromegaly market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
Acromegaly market report provides insights into the current and emerging therapies.
Acromegaly market report provides a global historical and forecasted market covering drug outreach in 7 MM.
Acromegaly market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Acromegaly market.
The Delveinsight’s Acromegaly market report helps to build a detailed comprehension of the historic, current, and forecasted Acromegaly market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.
Acromegaly market segment gives a thorough detail of Acromegaly market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
The Delveinsight’s Acromegaly epidemiology division provides insights about historical and current Acromegaly patient pool and forecasted trends for every seven major countries.
DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
The disease epidemiology covered in the report provides historical as well as forecasted Acromegaly epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030. The epidemiology segment also provides the Acromegaly epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
The launch of the emerging therapies is expected to significantly impact the Acromegaly treatment scenario in the upcoming years. Some of the drug covered in Acromegaly market report includes:
1. Octreotide capsules
2. Lanreotide PRF
And many others
The key players in Acromegaly market are:
1. Chiasma Pharma
2. Antisense Therapeutics
3. Crinetics Pharmaceuticals
And many others
Table of content
1. Key Insights
2. Executive Summary of Acromegaly
3. Competitive Intelligence Analysis for Acromegaly
4. Acromegaly Market Overview at a Glance
5. Acromegaly Disease Background and Overview
6. Acromegaly Patient Journey
7. Acromegaly Epidemiology and Patient Population
8. Acromegaly Treatment Algorithm, Current Treatment, and Medical Practices
9. Acromegaly Unmet Needs
10. Key Endpoints of Acromegaly Treatment
11. Acromegaly Marketed Products
12. Acromegaly Emerging Therapies
13. Acromegaly Seven Major Market Analysis
14. Acromegaly Attribute analysis
15. 7MM: Acromegaly Market Outlook
16. Access and Reimbursement Overview of Acromegaly
17. KOL Views
18. Acromegaly Market Drivers
19. Acromegaly Market Barriers
21. DelveInsight Capabilities
23. About DelveInsight
DelveInsight’s ‘Acromegaly Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Acromegaly epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
“Acromegaly Pipeline Insight, 2020” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acromegaly market. A detailed picture of the Acromegaly pipeline landscape is provided, which includes the disease overview and Acromegaly treatment guidelines.
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NEVADA 89107
Country: United States